Health

Dr. Smita Das from Stanford University highlights the real risk associated with off-label ketamine use. The dangers of a bad trip can have serious consequences for individuals who are not properly monitored or supervised during their use of this powerful substance. Dr. Shikha Jain from the University of Illinois draws attention to the unfair treatment
The term “problems in living” encapsulates the various challenges individuals face in managing their day-to-day activities. These issues can stem from psychological, emotional, social, or practical difficulties, all of which can significantly impact a person’s overall well-being and quality of life. Additionally, these problems are closely intertwined with social determinants of health, which encompass the
Optometrists in California, like Hunter Morgan, have faced challenges in providing care to Medicaid patients due to the low reimbursement rates offered by the state. Despite the increasing number of people on Medicaid, including all eligible adults, the rates paid to doctors have not kept up with the rising demand for services. This has made
The recent investigation into the London Clinic concerning the attempted access of Kate Middleton’s private medical records raises serious concerns about patient privacy and confidentiality. It is unacceptable for medical staff to breach these ethical boundaries, and the clinic must take immediate action to prevent such incidents from reoccurring. The decision by state health officials
Metachromatic leukodystrophy (MLD) is a rare genetic disease that affects the central nervous system and peripheral nervous system, leading to severe motor and cognitive impairment in children. The FDA recently approved atidarsagene autotemcel (arsa-cel; Lenmeldy) as the first gene therapy to treat children with pre-symptomatic late infantile, pre-symptomatic early juvenile, or early symptomatic early juvenile
A recent phase I study revealed exciting results for patients with heavily pretreated, platinum-resistant advanced ovarian cancer who were treated with raludotatug deruxtecan (R-DXd). The study, led by Kathleen Moore, MD, showed a remarkable overall response rate of 48.6% among patients who received R-DXd, an antibody drug conjugate (ADC) directed against cadherin 6 (CDH6). The
Recently, the CDC made headlines by reducing the isolation period for COVID-19 for the general public. This decision has sparked concerns from various organizations, including the National Nurses United (NNU). The implications of these weakened guidelines have raised questions about public health safety and the potential risks involved. The CDC’s revised isolation time for COVID-19
Neurological disorders have emerged as a significant health concern globally, affecting a staggering 3.4 billion people worldwide. According to the Global Burden of Disease Study, these conditions have become the leading cause of ill health and disability worldwide. Neurologic conditions have impacted 43.1% of the global population, surpassing cardiovascular diseases as the top contributor to